Recent studies revealed the association of abnormal methylomic changes with Alzheimer’s disease (AD) but there is a lack of systematic study of the impact of methylomic alterations over the molecular networks underlying AD.
Recent studies revealed the association of abnormal methylomic changes with Alzheimer’s disease (AD) but there is a lack of systematic study of the impact of methylomic alterations over the molecular networks underlying AD.